Correlation Between Shattuck Labs and Lumos Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shattuck Labs and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shattuck Labs and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shattuck Labs and Lumos Pharma, you can compare the effects of market volatilities on Shattuck Labs and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shattuck Labs with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shattuck Labs and Lumos Pharma.

Diversification Opportunities for Shattuck Labs and Lumos Pharma

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Shattuck and Lumos is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Shattuck Labs and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Shattuck Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shattuck Labs are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Shattuck Labs i.e., Shattuck Labs and Lumos Pharma go up and down completely randomly.

Pair Corralation between Shattuck Labs and Lumos Pharma

Given the investment horizon of 90 days Shattuck Labs is expected to under-perform the Lumos Pharma. In addition to that, Shattuck Labs is 5.46 times more volatile than Lumos Pharma. It trades about -0.23 of its total potential returns per unit of risk. Lumos Pharma is currently generating about -0.16 per unit of volatility. If you would invest  445.00  in Lumos Pharma on August 28, 2024 and sell it today you would lose (15.00) from holding Lumos Pharma or give up 3.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shattuck Labs  vs.  Lumos Pharma

 Performance 
       Timeline  
Shattuck Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shattuck Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Lumos Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lumos Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, Lumos Pharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Shattuck Labs and Lumos Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shattuck Labs and Lumos Pharma

The main advantage of trading using opposite Shattuck Labs and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shattuck Labs position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.
The idea behind Shattuck Labs and Lumos Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals